• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

局部晚期可切除头颈部鳞状细胞癌综合治疗的三年结果

Three-year results of combined modality therapy in locally advanced, resectable squamous cell carcinoma of the head and neck.

作者信息

Böheim K, Spoendlin H

出版信息

Acta Otolaryngol. 1985 Jul-Aug;100(1-2):134-9. doi: 10.3109/00016488509108598.

DOI:10.3109/00016488509108598
PMID:4024887
Abstract

Results of a combined therapy, consisting of preoperative chemotherapy, radical resection and postoperative irradiation, of 51 locally advanced, previously untreated, resectable squamous cancers of the head and neck are reported. The overall response rate to chemotherapy was 58.5% (with 33% complete remissions) and higher in carcinomas of the oral cavity and hypopharynx than of the supraglottis and oropharynx. Three year survival was 53% for the entire group, 75% for hypopharyngeal, 58% for oral, 50% for supraglottic and 32% for oropharyngeal lesions, in responders to chemotherapy statistically significant higher than in non responders and only 18% in the fifteen patients who developed recurrences.

摘要

报告了对51例局部晚期、未经治疗、可切除的头颈部鳞状癌采用术前化疗、根治性切除和术后放疗的联合治疗结果。化疗的总体缓解率为58.5%(完全缓解率为33%),口腔和下咽癌的缓解率高于声门上区和口咽癌。整个组的三年生存率为53%,下咽癌为75%,口腔癌为58%,声门上区癌为50%,口咽癌为32%;化疗有反应者的生存率在统计学上显著高于无反应者,在出现复发的15例患者中生存率仅为18%。

相似文献

1
Three-year results of combined modality therapy in locally advanced, resectable squamous cell carcinoma of the head and neck.局部晚期可切除头颈部鳞状细胞癌综合治疗的三年结果
Acta Otolaryngol. 1985 Jul-Aug;100(1-2):134-9. doi: 10.3109/00016488509108598.
2
The incidence of metastases after multimodal therapy for cancer of the head and neck.头颈部癌多模式治疗后的转移发生率。
Cancer. 1984 Nov 1;54(9):2009-14. doi: 10.1002/1097-0142(19841101)54:9<2009::aid-cncr2820540938>3.0.co;2-3.
3
Outcome of locally advanced stage III and IV head and neck cancer treated by surgery and postoperative external beam radiotherapy.接受手术及术后体外照射放疗的局部晚期III期和IV期头颈癌的治疗结果。
Laryngoscope. 1987 May;97(5):615-20. doi: 10.1288/00005537-198705000-00016.
4
Rapidly alternating chemotherapy and hyperfractionated radiotherapy in the management of locally advanced head and neck carcinoma: four-year results of a phase I/II study.局部晚期头颈癌治疗中快速交替化疗与超分割放疗:一项I/II期研究的四年结果
J Clin Oncol. 1994 Sep;12(9):1876-85. doi: 10.1200/JCO.1994.12.9.1876.
5
Multimodality treatment including postoperative radiation and concurrent chemotherapy with weekly docetaxel is feasible and effective in patients with oral and oropharyngeal cancer.包括术后放疗以及每周使用多西他赛进行同步化疗在内的多模式治疗,对于口腔癌和口咽癌患者而言是可行且有效的。
Strahlenther Onkol. 2005 Jan;181(1):26-34. doi: 10.1007/s00066-005-1272-3.
6
Intensified regimen for advanced head and neck squamous cell carcinomas.
Arch Otolaryngol Head Neck Surg. 1997 Feb;123(2):139-44. doi: 10.1001/archotol.1997.01900020013002.
7
[Combination of induction chemotherapy with surgery and/or radiotherapy in locally advanced head and neck cancers. A retrospective analysis of a series of 125 patients].[局部晚期头颈癌诱导化疗联合手术和/或放疗。对125例患者的系列回顾性分析]
Bull Cancer. 1997 Sep;84(9):863-8.
8
Randomized trial comparing surgery and adjuvant radiotherapy versus concurrent chemoradiotherapy in patients with advanced, nonmetastatic squamous cell carcinoma of the head and neck: 10-year update and subset analysis.随机对照试验比较手术和辅助放疗与同期放化疗治疗晚期局部非转移性头颈部鳞状细胞癌患者:10 年更新和亚组分析。
Cancer. 2015 May 15;121(10):1599-607. doi: 10.1002/cncr.29251. Epub 2015 Jan 29.
9
Low-dose preoperative chemoradiation therapy compared with surgery alone with or without postoperative radiotherapy in patients with head and neck carcinoma.头颈部癌患者中,低剂量术前放化疗与单独手术加或不加术后放疗的比较。
Ann Surg Oncol. 2011 Oct;18(10):2739-47. doi: 10.1245/s10434-011-1643-1. Epub 2011 Mar 22.
10
Mature results from a randomized Phase II trial of cisplatin plus 5-fluorouracil and radiotherapy with or without tirapazamine in patients with resectable Stage IV head and neck squamous cell carcinomas.顺铂联合5-氟尿嘧啶及放疗加或不加替拉扎明用于可切除的IV期头颈部鳞状细胞癌患者的随机II期试验的成熟结果。
Cancer. 2006 May 1;106(9):1940-9. doi: 10.1002/cncr.21785.

引用本文的文献

1
Cisplatin-induced ototoxicity: audiometric findings and experimental cochlear pathology.顺铂诱导的耳毒性:听力测定结果与实验性耳蜗病理学
Arch Otorhinolaryngol. 1985;242(1):1-6. doi: 10.1007/BF00464398.
2
Chemotherapeutic management of head and neck cancer.
Cancer Metastasis Rev. 1987;6(3):181-98. doi: 10.1007/BF00144263.
3
Chemotherapy in head and neck cancer with bleomycin, cisplatinum, and methotrexate.头颈部癌采用博来霉素、顺铂和甲氨蝶呤进行化疗。
J Cancer Res Clin Oncol. 1988;114(6):644-6. doi: 10.1007/BF00398192.
4
The prognostic influence of induction chemotherapy on advanced head and neck carcinoma.诱导化疗对晚期头颈癌的预后影响。
Arch Otorhinolaryngol. 1986;243(5):324-8. doi: 10.1007/BF00460211.
5
Nutritional and immunological investigations in head and neck cancer patients before and after therapy.头颈部癌症患者治疗前后的营养与免疫调查。
Arch Otorhinolaryngol. 1985;242(2):149-53. doi: 10.1007/BF00454414.